-
Pharma patent litigation updates: Boehringer, Orion, Pfizer, Kaleo file fresh patent infringement suits in District of Delaware
Read more: Pharma patent litigation updates: Boehringer, Orion, Pfizer, Kaleo file fresh patent infringement suits in District of DelawareThe District of Delaware continues to receive a substantial volume of pharmaceutical patent infringement complaints, with an arthritis-related Pfizer suit and diabetes-related Boehringer suit among the latest.
-
Hyundai, Nissan defeat parallel automotive patent infringement complaints in Eastern District of Texas
Read more: Hyundai, Nissan defeat parallel automotive patent infringement complaints in Eastern District of TexasJudge Rodney Gilstrap has ruled that Longhorn Automotive LLC’s patent infringement complaints against the automakers did not sufficiently meet the burden of proof.
-
BREAKING: ETSI creates new committee on quantum technologies
Read more: BREAKING: ETSI creates new committee on quantum technologiesThe European Telecommunications Standards Institute has approved the creation of a new Technical Committee on Quantum Technologies, ahead of a major European event on quantum ambition.
-
Munich I Regional Court’s stunning PI for 20+ countries: based on BSH, doctrine of equivalents, difficult-to-enforce formulation patent
Read more: Munich I Regional Court’s stunning PI for 20+ countries: based on BSH, doctrine of equivalents, difficult-to-enforce formulation patentMunich has been a patent injunction hotspot for many years, and the latest development may attract even more litigation to the venue.
-
Samsung to pay $78 million in media ad monitoring patent infringement suit, parallel suit against Roku may be revived
Read more: Samsung to pay $78 million in media ad monitoring patent infringement suit, parallel suit against Roku may be revivedAnonymous Media Holdings, LLC has been granted a motion for partial summary judgment of validity in its case against Samsung.
-
AstraZeneca faces fresh mRNA patent infringement allegations in District of Delaware
Read more: AstraZeneca faces fresh mRNA patent infringement allegations in District of DelawareGene-editing tech company Factor Bioscience has sued AstraZeneca and its affiliate Cellectis over the infringement of three mRNA-related patents.
-
UPC Roundup (1 week): another trade fair inspection order; two UPC confidentiality decisions and one in India with reference to UPC
Read more: UPC Roundup (1 week): another trade fair inspection order; two UPC confidentiality decisions and one in India with reference to UPCThis is a summary of developments in and around the Unified Patent Court (UPC) in the week since our September 21, 2025 UPC Roundup.
-
Starbucks invokes anti-patent-troll state law in major defensive complaint against Key Patent Innovations and its shell company
Read more: Starbucks invokes anti-patent-troll state law in major defensive complaint against Key Patent Innovations and its shell companyThis is one of the most notable prophylactic patent-related lawsuits because it takes aim at a non-practicing entity’s shell company from multiple angles.
Follow Us
Latest Articles
- UPC Roundup (1 week): 4G action consolidated with later-filed 5G complaint against same party; Hague LD finds no UPC jurisdiction over BYD UK; more
- Eyeing the AI data center boom, Via Licensing Alliance unveils new NAND pool, issues call for patents
- Ibex sues Disney and Snap in Brazil as streaming patent disputes escalate
- Brazilian court lifts ZTE’s 5G injunction against Samsung as expert rejects infringement and essentiality claims
- Podcast: interview with Dr. Peter Georg Picht, SEP and competition law expert